Correlation between rhodamine 123 accumulation and azole sensitivity in Candida species: Possible role for drug efflux in drug resistance

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 2, 1996, Pages 419-425

  Clark, F S ^a   Parkinson, T ^b   Hitchcock, C A ^b   Gow, N A R ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

1 (2,4 DICHLOROPHENYL) 1 (4 FLUOROPHENYL) 2 (1,2,4 TRIAZOL 1 YL)ETHANOL; FLUCONAZOLE; GLYCOPROTEIN P; ITRACONAZOLE; KETOCONAZOLE; METHOTREXATE; PYRROLE DERIVATIVE; RESERPINE; RHODAMINE 123;

ARTICLE; CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; DRUG ACCUMULATION; DRUG SENSITIVITY; DRUG TRANSPORT; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL;

EID: 0030025637     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.2.419     Document Type: Article

References (56)

1. Ambudkar, S. V., I. H. Lelong, J. Zhang, C. D. Cardelli, M. M. Gottesman, and I. Pastan. 1992. Partial purification and reconstitution of the human MDR pump: characterization of the drug stimulatable ATP hydrolysis. Proc. Natl Acad. Sci. USA 89:8472-8476
2. Aoki, S., and S. Ito-Kuwa. 1982. Respiration of Candida albicans in relation to its morphogenesis. Plant Cell Physiol. 23:721-726.
3. Aoki, S., and S. Ito-Kuwa, 1985. Inhibitor susceptibility of the cyanide-resistant pathway in Candida albicans Jpn. J. Oral Biol 27:737-740.
4. Balzi, E., and A. Goffeau. 1991. Multiple or pleiotropic drug resistance in yeast. Biochim. Biophys. Acta 1073:241-252.
5. Balzi, E., and A. Goffeau. 1994. Genetics and biochemistry of yeast multidrug resistance. Biochim. Biophys Acta 1187:152-162.
6. Balzi, E., M. Wang, S. Leterme, L. Van Dyke, and A. Goffeau. 1994 PDR5, a novel yeast multidrug resistance conferring transporter controlled by the transcriptional regulator PDR1. J. Biol. Chem. 269:2206-2214.
7. Barrett-Bee, K., and N. Ryder. 1992. Biochemical aspects of ergosterol biosynthesis inhibition, p 410-436. In J. Sutcliffe and N. H. Georgopapadakou (ed.), Emerging targets in antibacterial and antifungal chemotherapy. Chapman & Hall, New York.
8. Ben-Yaacov, R., S. Knoller, G. A. Caldwell, J. M. Becker, and Y. Koltin. 1994 Candida albicans gene encoding resistance to benomyl and methotrexate is a multidrug resistance gene. Antimicrob. Agents Chemother 38:648-652
9. Berna, S. D., T. J. Lampid, I. C. Summerhay, and L. B. Chen. 1982. Rhodamine-123 selectively reduces clonal growth of carcinoma cells in vitro Science 218:1117-1118
10. Broxterman, H. J., H. M. Pinedo, C. M. Kuiper, L. C. M. Kaptein, G. J. Schuurhuis, and J. Lankelman. 1988 Induction by verapamil of a rapid increase in ATP consumption in multidrug-resistant tumor cells. FASEB J. 2:2278-2282.
11. Buchan, A. D. B., and N. A. R. Gow. 1992. Rates of germ tube formation from growing and non-growing germ tubes of Candida albicans. FEMS Microbiol. Lett. 81:15-18
12. Chaudhary, P. M., and I. B. Roninson. 1991 Expression and activity of P-glycoprotein, a multidrug efflux pump, in human hematopoietic stem cells. Cell 66:85-94.
13. Cornwell, M. M., T. Tsuro, M. M. Gottesman, and I. Patan. 1987. ATP-binding properties of P-glycoprotein from multidrug resistant KB cells. FASEB J. 1:51-54.
14. Crombie, T., D. J. Falconer, and C. A. Hitchcock. 1995. Fluconazole resistance due to energy-dependent efflux in Candida glabrata. Antimicrob. Agents Chemother 39:1696-1699.
15. Crombie, T., and C. A. Hitchcock. Unpublished observations
16. Dexter, D., W. S. Moye-Rowley, A.-L. Wu, and J. Golin. 1994 Mutations in the yeast PDR3, PDR4, PDR7 and PDR9 pleiotropic (multiple) drug resistance loci affect transcript level of an ATP binding cassette transporter encoding gene, PDR5. Genetics 136:505-515.
17. Efferth, T., H. Lohrke, and M. Volm. 1989. Reciprocal correlation between expression of P-glycoprotein and accumulation of Rhodamine 123 in human tumors Anticancer Res. 9:1633-1638.
18. Faith, M. J., and R. Kolter. 1993 ABC transporters: bacterial exporters. Microbiol. Rev. 57:995-1017.
19. Ford, J. M., and W. N. Hait. 1990 Pharmacology of drugs that alter multidrug resistance in cancer. Pharmacol. Rev. 42:155-198
20. Gallagher, P. J., D. E. Bennett, M. C. Henman, R. J. Russell, S. R. Flint, D. B. Shanley, and D. C. Coleman. 1992 Reduced azole susceptibility of oral isolates of Candida albicans from HIV-positive patients and a derivative exhibiting colony morphology variation. J. Gen Microbiol. 138:1901-1911.
21. Hamada, H., and T. Tsuruo. 1988. Purification of the 170- to 180-kilodalton membrane glycoprotein associated with multidrug resistance. J Biol. Chem. 263:1454-1458.
22. Hill, B. T., and L. K. Hosking. 1994. Differential effectiveness of a range of novel drug-resistance modulators, relative to verapamil, in influencing vinblastine or teniposide cytotoxicity in human lymphoblastoid CCRF-CEM sublines expressing classic or atypical multidrug resistance. Cancer Chemother Pharmacol. 33:317-324
23. Hitchcock, C. A. 1993. Resistance of Candida albicans to antifungal agents Biochem. Soc Trans. 41:1039-1047.
24. Hitchcock, C. A., K. J. Barrett-Bee, and N. J. Russell. 1986. The lipid composition of azole-sensitive and azole-resistant strains of Candida albicans. J Gen Microbiol 132:2421-2431.
25. Hitchcock, C. A., G. W. Pye, P. F. Troke, E. M. Johnson, and D. W. Warnock. 1993. Fluconazole resistance in Candida glabrata. Antimicrob. Agents Chemother. 37:1962-1965.
26. Horio, M., M. M. Gottesman, and I. Pastan. 1988. ATP-dependent transport of vinblastine in vesicles from human multidrug-resistant cells. Proc Natl. Acad Sci. USA 85:3580-3584
27. Horsburgh, C. R., and C. H. Kirkpatrick. 1983 Long-term therapy of chronic mucocutaneous candidiasis with ketoconazole, experience with twenty-one patients. Am J Med. 74:23-29
28. Howell, S. A., A. I. Mallet, and W. C. Noble. 1990 A comparison of the sterol content of multiple isolates of the Candida albicans Darlington strain with other clinically azole-sensitive and -resistant strains J. Appl. Bacteriol. 69: 692-696
29. Jancis, E. M., R. Carbone, K. J. Loechner, and P. S. Dannis. 1993. Estradiol induction of Rhodamine 123 efflux and the multidrug resistance pump in rat pituitary tumor cells. Mol. Pharmacol. 43:51-56.
30. Johnson, L. V., M. L. Walsh, and L. B. Chen. 1980. Localization of mitochondria in living cells with Rhodamine 123. Proc. Natl Acad Sci USA 77:990-994.
31. Juliano, R. L., and V. Ling. 1976. A surface grycoprotein modulating drug permeability in CHO cell mutants. Biochim Biophys. Acta 455:152-162.
32. Juranka, P. F., R. L. Zastawny, and V. Ling. 1989 P-glycoprotein: multidrug resistance and a superfamily of membrane-associated transport proteins. FASEB J. 3:2583-2592
33. Lomovskaya, O., and K. Lewis. 1992 emr, an Escherichia coli locus for multidrug resistance. Proc. Natl. Acad Sci. USA 89:8938-8942.
34. Miyauchi, S., M. Komatsubara, and N. Kamo. 1992. In archaebacteria, there is a doxorubicin efflux pump similar to mammalian P-glycoprotein. Biochim. Biophys. Acta 1110:144-150.
35. Neyfakh, A. A., V. E. Bidnenko, and L. B. Chen. 1991 Efflux mediated mukidrug resistance in Bacillus subtilis: similarities and dissimilarities with the mammalian system Proc Natl. Acad. Sci. USA 88:4781-4785
36. Neyfakh, A. A., C. M. Borsch, and G. W. Kaatz. 1993. Fluoroquinolone resistance protein NorA of Staphylococcus aureus is a multidrug efflux transporter. Antimicrob. Agents Chemother. 37:128-129.
37. Neyfakh, A. A., A. S. Serpinskaya, A. V. Chervonsky, S. G. Apasov, and A. R. Kazarov. 1989 Multidrug-resistance phenotype of a subpopulation of T-lymphocytes without drug selection. Exp. Cell Res. 185:496-505.
38. Odds, F. C. 1988. Candida and candidosis, 2nd ed. Bailliere Tindall, London.
39. Odds, F. C. 1993. Resistance of yeasts to azole-derivative antifungals. J. Antimicrob Chemother. 31:463-471.
40. Ouellette, M., D. Légaré, and B. Papadopoulou. 1994. Microbial multi-drug resistance ABC transporters. Trends Microbiol. 2:407-411.
41. Pearce, H. L., A. R. Safa, N. J. Bach, M. A. Winter, and M. C. Cirtain. 1989. Essential features of the P-glycoprotein pharmacophore as defined by a series of reserpine analogs that modulate multidrug resistance. Proc. Natl. Acad. Sci. USA 86:5128-5132.
42. Pfaller, M. A., M. G. Rinaldi, J. N. Galgiani, M. S. Bartlett, B. B. Body, A. Espinel-Ingroff, R. A. Fromtling, G. S. Hall, C. E. Hughes, F. C. Odds, and A. M. Sugar. 1990. Collaborative investigation of variables in susceptibility testing of yeasts. Antimicrob. Agents Chemother 34:1648-1654.
43. Prasad, R., P. de Wergifosse, A. Goffeau, and E. Balzi. 1995. Molecular cloning and characterization of a novel gene of Candida albicans, CDR1, conferring multiple resistance to drugs and antifungals. Curr Genet. 27:320-329.
44. Rex, J. H., M. G. Rinaldi, and M. A. Pfaller. 1995. Resistance of Candida species to fluconazole Antimicrob. Agents Chemother. 39:1-8.
45. Ruchel, R. 1983. On the renin-like activity of Candida proteinases and activation of blood coagulation in vitro. Zentralbl. Bakteriol. Hyg. 255:368-379
46. Ryley, J. F., R. G. Wilson, and K. J. Barrett-Bee. 1984. Azole resistance in Candida albicans Sabouraudia 22:53-63.
47. Scholer, H. J., and A. Polak. 1984. Resistance to systemic antifungal agents. p. 393-483. Academic Press, Inc., New York.
48. Sehested, M., T. Skovsgaard, P. B. Jensen, E. J. F. Demant, E. Friche, and N. Bindslev. 1990. Transport of the multidrug resistance modulators verapamil and azadopine in wild type and daunorubicin resistant Ehrlich ascites tumor cells. Br. J. Cancer 62:37-41.
49. Sherman, F. 1991. Getting started with yeast Methods Enzymol. 194:3-21.
50. Togni, G., D. Sanglard, R. Falchetto, and M. Monod. 1991. Isolation and nucleotide sequence of the extracellular acid protease gene (ACP) from the yeast Candida tropicalis. FEBS Lett 286:181-185.
51. Vanden Bossche, H., P. Marichal, J. Gorrens, D. Bellens, H. Moereels, and P. A. J. Janssen. 1990. Mutation in cytochrome P-450-dependent 14α-demethylase results in decreased affinity for azole antifungals. Biochem. Soc. Trans. 18:56-59.
52. Vanden Bossche, H., P. Marichal, and F. C. Odds. 1994. Molecular mechanisms of drug resistance in fungi. Trends Microbiol. 2:393-100.
53. Wang, Y. C., and D. Kerridge. Personal communication.
54. Whelan, W. L., and P. T. Magee. 1981 Natural heterozygosity in Candida albicans. J Bacteriol 145:896-903.
55. Willocks, L., C. L. S. Leen, R. P. Brettle, D. Urquart, T. B. Russell, and L. J. R. Milne. 1991. Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole. N. Engl. J. Med. 325:1274-1277.
56. Yamaguchi, H. 1974. Dimorphism in Candida albicans I. Morphology-dependent changes in content of macromolecules and respiratory activity. J. Gen Appl. Microbiol. 20:87-99.